Anlotinib Combined With Etoposide and Platinum in the Treatment of Lung Cancer
Clinical trial NCT03841136 · UNKNOWN
Trial details
- NCT number
- NCT03841136
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-01
- Primary completion
- 2019-12-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.